COMMUNIQUÉS West-GlobeNewswire

BioDelivery Sciences to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8, 2019
30/07/2019
RALEIGH, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced its [...]
Aptose Biosciences to Present at Canaccord Genuity 39th Annual Growth Conference
30/07/2019
SAN DIEGO and TORONTO, July 30, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of [...]
Meridian Bioscience Reports Third Quarter 2019 Operating Results
30/07/2019
CINCINNATI, Ohio, July 30, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the third quarter and first nine months ended June 30, 2019. Third Quarter 2019 [...]
Matinas BioPharma to Webcast Conference Call Discussing Second Quarter 2019 Operational and Financial Results on August 13, 2019
30/07/2019
BEDMINSTER, N.J., July 30, 2019 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live [...]
Diroximel Fumarate Demonstrated Significantly Improved Gastrointestinal Tolerability Profile Compared to Dimethyl Fumarate in Patients with Multiple Sclerosis
30/07/2019
— Diroximel Fumarate Demonstrated Statistically Superior Gastrointestinal (GI) Tolerability on EVOLVE-MS-2 Study’s Primary Endpoint Assessing Self-Reported GI Events — — Discontinuations Due to GI Events were Less than [...]
T2 Biosystems to Present at the Canaccord Genuity Growth Conference
30/07/2019
LEXINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs [...]
Chi-Med Reports 2019 Interim Results and Provides Updates on Key Clinical Programs
30/07/2019
LONDON, July 30, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (AIM/Nasdaq: HCM) today announces its unaudited financial results for the six months ended June 30, 2019 and provides updates on [...]
Curetis and AKO MED Ink Distribution Agreement Covering Four Countries in CEE Region
30/07/2019
- AKO MED to exclusively distribute Unyvero A50 portfolio in Serbia, North Macedonia, Bosnia Hercegovina, and Montenegro - Preparing inclusion of Unyvero in several regional tender offers Amsterdam, the Netherlands, San [...]
Verona Pharma to Announce Financial Results for Second Quarter Ended June 30, 2019 and Provide Clinical Development Update
30/07/2019
LONDON, July 30, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on respiratory diseases, today announces that it will report [...]
Bone Therapeutics SA: Information on the total number of voting rights and shares
30/07/2019
Regulated information Gosselies, Belgium, 30 July 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological [...]
Bone Therapeutics SA : Information relative au nombre total de droits de vote et d’actions
30/07/2019
Information réglementée Gosselies, Belgique, le 30 juillet 2019, 07h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies [...]
Coherus BioSciences Reports Victory in Pegfilgrastim Patent Dispute
30/07/2019
REDWOOD CITY, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or “the Company”, Nasdaq: CHRS), today announced that the United States Court of Appeals for the Federal Circuit has affirmed [...]
MediciNova Announces MN-166 (ibudilast) ALS Abstract Accepted for Presentation at the 30th International Symposium on ALS/MND in Perth, Australia
30/07/2019
LA JOLLA, Calif., July 29, 2019 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Alimera Sciences Announces Second Quarter 2019 Financial Results and Provides Corporate Update
30/07/2019
Second Quarter and Recent Company Highlights: Consolidated Net Revenue Up 2% Compared to Second Quarter 2018 International Net Revenue Up 21% Compared to Second Quarter 2018 UK’s NICE Provided Positive Opinion for [...]
iCAD to Report Second Quarter 2019 Financial Results on Thursday, August 1
29/07/2019
NASHUA, N.H., July 29, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial [...]
Taconic Biosciences lance le premier modèle animal commercial de la NASH
29/07/2019
Ce nouveau modèle apporte des gains de temps aux chercheurs étudiant cette maladie dévastatrice RENSSELAER, N.Y., 29 juill. 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, un chef de file mondial dans la fourniture de [...]
Amarin Announces Underwriters’ Full Exercise of Option to Purchase Additional American Depositary Shares
29/07/2019
BEDMINSTER, N.J., and DUBLIN, Ireland, July 29, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that, in connection with its previously announced underwritten public offering of American [...]
Cambium Networks Corporation Announces Second Quarter Fiscal 2019 Reporting Date
29/07/2019
ROLLING MEADOWS, Ill., July 29, 2019 (GLOBE NEWSWIRE) -- Cambium Networks Corporation (“Cambium”) (NASDAQ: CMBM), a leading provider of wireless broadband networking infrastructure solutions, today announced that it [...]
Rockwell Medical, Inc. to Discuss Second Quarter 2019 Financial Results on August 8, 2019
29/07/2019
WIXOM, Mich., July 29, 2019 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. ("Rockwell Medical" or the “Company”) (Nasdaq: RMTI) today announced that the Company will release its 2019 second quarter financial results on [...]

Pages